Oncology

Oncology

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
101-120 of 232 ARTICLES
https://doi.org/10.12688/f1000research.129658.1
Case Report metrics
Case Report: Metachronous urothelial carcinoma of the renal pelvis following radical cystectomy: a rare case report
[version 1; peer review: 1 approved]
Peer Reviewers Pradeep Singh Chauhan
PUBLISHED 23 Jun 2023
https://doi.org/10.12688/f1000research.134816.1
Research Article metrics
Patient’s attitudes and perceptions around attending oncology consultations following surgery for colorectal cancer: A qualitative study
[version 1; peer review: 3 approved]
Peer Reviewers Shanaz Ghuman; Haniee Chung; Rajesh Balkrishnan
  • Funder
  • National Institutes of Health
PUBLISHED 19 Jun 2023
https://doi.org/10.12688/f1000research.113303.2
Research Article metrics
Revised
The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia
[version 2; peer review: 2 approved]
Peer Reviewers Fariz Nurwidya; Darren Wan-Teck Lim
LATEST VERSION PUBLISHED 15 Jun 2023
https://doi.org/10.12688/f1000research.132303.1
Case Report metrics
Case Report: A rare case of mucinous adenocarcinoma of the female urethra
[version 1; peer review: 1 approved with reservations, 1 not approved]
Peer Reviewers Ivan Putrantyo; Ting Zhao
PUBLISHED 13 Jun 2023
https://doi.org/10.12688/f1000research.132034.2
Systematic Review metrics
Revised
The role of salivary orosomucoid 1 as an early diagnostic and prognostic biomarker of hepatocellular carcinoma related to Hepatitis B: A systematic review
[version 2; peer review: 1 approved, 1 not approved]
Peer Reviewers Maria Komariah and Sidik Maulana; Antonio Giovanni Solimando
LATEST VERSION PUBLISHED 06 Jun 2023
https://doi.org/10.12688/f1000research.128716.2
Review metrics
Revised
Circadian clocks in health and disease: Dissecting the roles of the biological pacemaker in cancer
[version 2; peer review: 2 approved]
Peer Reviewers Phillip Karpowicz; Kristin Eckel-Mahan
  • Funders
  • American Cancer Society
  • National Institutes of Health
  • Johnson and Johnson
  • V Foundation for Cancer Research
LATEST VERSION PUBLISHED 16 May 2023
https://doi.org/10.12688/f1000research.134088.1
Research Article metrics
Predictive factors of large liver cell carcinoma tumor response after first conventional transarterial chemoembolization in Indonesia according to the modified response evaluation in solid tumors criteria: a preliminary study
[version 1; peer review: 1 not approved]
Peer Reviewers Shiro Miyayama
PUBLISHED 15 May 2023
https://doi.org/10.12688/f1000research.133275.1
Research Article metrics AWAITING PEER REVIEW
Comparative evaluation of serum interleukin 6 with neutrophil - lymphocyte and platelet -lymphocyte ratio in pre and post-surgery oral squamous cell carcinoma.
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
  • Funder
  • Datta Meghe Institute of Higher Education and Research (Intramural Grant)
PUBLISHED 15 May 2023
https://doi.org/10.12688/f1000research.122741.2
Study Protocol metrics
Revised
Protocol for a randomized study of the efficacy of ibandronic acid plus eldecalcitol in patients with gastric cancer after gastrectomy: A comparative study of different routes of administration of ibandronic acid
[version 2; peer review: 2 approved]
Peer Reviewers Carlen Reyes; Friederike Thomasius
LATEST VERSION PUBLISHED 05 May 2023
https://doi.org/10.12688/f1000research.131414.1
Research Article metrics
Preserved correlation matrices pinpoint extracellular matrix organization as a critical factor in pancreatic ductal adenocarcinoma
[version 1; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Stephan Joel Reshkin; Howard Crawford
  • Funder
  • Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
PUBLISHED 18 Apr 2023
https://doi.org/10.12688/f1000research.130329.1
Systematic Review metrics
Benefit of Asian pigmented rice bioactive compound and its implication in breast cancer: a systematic review
[version 1; peer review: 2 approved, 1 approved with reservations, 1 not approved]
Peer Reviewers Kok-Yong Chin; Ananto Ali Alhasyimi; Mohammed Aljunaid; Yuan Seng Wu
PUBLISHED 05 Apr 2023
https://doi.org/10.12688/f1000research.122987.2
Brief Report metrics
Revised
Improving the predictive power of xenograft and syngeneic anti-tumour studies using mice humanised for pathways of drug metabolism
[version 2; peer review: 2 approved]
Peer Reviewers Russ Prough; Chris Goldring
  • Funders
  • Cancer Research UK
  • Medical Research Council
  • National Centre for the Replacement Refinement and Reduction of Animals in Research
LATEST VERSION PUBLISHED 27 Mar 2023
https://doi.org/10.12688/f1000research.125858.1
Research Article metrics
Neutrophil/lymphocyte ratio and overall survival in patients with breast cancer: a cohort study in a Latin-American hospital
[version 1; peer review: 1 approved with reservations]
Peer Reviewers Helene Rundqvist and Marlene Rietz
PUBLISHED 24 Mar 2023
https://doi.org/10.12688/f1000research.129860.2
Research Article metrics
Revised
Ocimum sanctum Linn. Ethanolic extract promotes an antiproliferative and apoptosis activity in MCF-7 and T47D breast cancer cell lines mediated by upregulation of ROS/RNS, Caspase 9, and Caspase 3: an in silico and in vitro study
[version 2; peer review: 1 approved, 1 not approved]
Peer Reviewers Muhammad Lokman MD Isa; Stéphanie Grandemange
LATEST VERSION PUBLISHED 24 Mar 2023
https://doi.org/10.12688/f1000research.131710.1
Review metrics PEER REVIEW DISCONTINUED
Data presentation of results from randomized cancer clinical trials. The case for trials in advanced cervical cancer. A critical appraisal.
[version 1; peer review: peer review discontinued]
Peer Reviewers Invited
  • Funder
  • The author declared that no grants were involved in supporting this work.
PUBLISHED 13 Mar 2023
https://doi.org/10.12688/f1000research.130888.1
Research Article metrics AWAITING PEER REVIEW
Network biology of lapatinib resistance in different types of HER2-positive breast cancers informs the prioritization of the combination anticancer treatments as anti-resistance interventions
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
PUBLISHED 09 Mar 2023
https://doi.org/10.12688/f1000research.130716.1
Clinical Practice Article metrics
Oncoplastic breast volume replacement with the use of lateral intercostal artery perforator flap
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Dedy Hermansyah; Kanchana Wijesinghe
PUBLISHED 01 Mar 2023
https://doi.org/10.12688/f1000research.109136.2
Research Article metrics
Revised
Genomic profiles of Indonesian colorectal cancer patients
[version 2; peer review: 2 approved]
Peer Reviewers Ahmad Rusdan Handoyo Utomo; Wei Zhang
  • Funder
  • Indonesian Ministry of Research, Technology, and Higher Education through the World Class Research (WCR) 2019 Program
LATEST VERSION PUBLISHED 21 Feb 2023
https://doi.org/10.12688/f1000research.129490.1
Research Article metrics
Toblerone: detecting exon deletion events in cancer using RNA-seq
[version 1; peer review: 2 approved]
Peer Reviewers Katherine Pillman; Matt Field
  • Funder
  • National Health and Medical Research Council
PUBLISHED 03 Feb 2023
https://doi.org/10.12688/f1000research.127325.1
Research Article metrics
Multimorbidity in Sudanese women newly diagnosed with breast cancer: a retrospective cross-sectional study
[version 1; peer review: 1 approved with reservations]
Peer Reviewers Phumudzo Ndwambi
PUBLISHED 23 Jan 2023
101-120 of 232 ARTICLES
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.